dermatan sulfate has been researched along with Thrombocytopenia in 214 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (2.80) | 18.7374 |
| 1990's | 84 (39.25) | 18.2507 |
| 2000's | 100 (46.73) | 29.6817 |
| 2010's | 24 (11.21) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jennings, W; Mallios, A | 1 |
| Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J | 1 |
| Prince, M; Wenham, T | 1 |
| Arepally, GM; Chong, BH; Cines, DB; Cuker, A; Greinacher, A; Gruel, Y; Linkins, LA; Morgan, RL; Mustafa, RA; Rodner, SB; Santesso, N; Selleng, S; Warkentin, TE; Wex, A | 1 |
| Castelino, RL; Kairaitis, L; Maddula, M; Sud, K; Tarafdar, S | 1 |
| Arnold, DM; Bates, SM; Kelton, JG | 1 |
| Babović, I; Karapandzić, VP; Plesinac, S | 1 |
| Alings, AM; de Bree, LC; van Wijngaarden, P | 1 |
| Harler, U; Joannidis, M; Lehner, GF; Pechlaner, C; Schöpf, M | 1 |
| Greinacher, A | 3 |
| Horlait, G; Michaux, I; Minet, V; Mullier, F | 1 |
| Baumgarten, G; Kim, S; Koster, A; Riedel, R; Schewe, JC; Schmieder, A | 1 |
| Camoin-Jau, L; Collart, F; Grisoli, D; Habib, G; Jaussaud, N; Ronchard, T; Salaun, E; Theron, A | 1 |
| Bauer, KA; Donati, MB; Gould, M; Hirsh, J; Samama, MM; Weitz, JI | 1 |
| Fürll, B; Greinacher, A; Kohlmann, T; Krauel, K; Sheppard, JI; Warkentin, TE; Weitschies, W | 1 |
| Chong, BH; Isaacs, A | 1 |
| Christoffersen, C; Gøtze, JP; Lethagen, S | 1 |
| Cleret, B; de Maistre, E; Elalamy, I; Gruel, Y; Lecompte, T; Mulot, A; Nguyen, P; Pouplard, C; Tardy, B; Tardy-Poncet, B | 1 |
| Chong, BH; Lip, GYH; Shantsila, E | 1 |
| Borzanović, MD; Calija, BM; Djukanović, BP; Jović, MD; Knezević, AM; Krivokapić, BM; Nenadić, DS; Nezić, DG; Petrović, IM | 1 |
| Cohen, J; Inbal, A; Shapiro, M; Singer, P | 1 |
| Jaussaud, M; Léon, A; Lepouse, C; Murat, O; Perrier, S; Petit, JS | 1 |
| Bidet, A; de Maistre, E; Desprez, D; Grunebaum, L; Huisse, MG; Lavenu-Bombled, C; Lecompte, T; Morange, P; Mouton, C; Pouplard, C; Presles, E; Racadot, E; Tardy Poncet, B; Tardy, B; Wolf, M | 1 |
| Hähnel, S; Hertle, DN; Kiening, KL; Richter, GM; Sakowitz, OW; Unterberg, A | 1 |
| Ducrocq, X; Lacour, JC; Lavandier, K; Perrin, J; Richard, S | 1 |
| Clark, M; Fareed, J; Gomes, M; Hoppensteadt, D; Ramacciotti, E; Sadeghi, N; Thethi, I | 1 |
| Hull, R; Walenga, J | 1 |
| Ajzenberg, N; Aubier, B; Dilly, MP; Dufour, G; Lepage, L; Longrois, D; Montravers, P; Provenchere, S; Ricome, S | 1 |
| Antovic, JP; Armstrong, E; Baghaei, F; Dalsgaard-Nielsen, J; Hillarp, A; Holme, PA; Holmström, M; Johnsson, H; Joutsi-Korhonen, L; Lassila, R; Sandset, PM | 1 |
| Akrour, M; Chapelle, C; Combe, M; Piot, M; Tardy, B; Tardy-Poncet, B | 1 |
| Warkentin, TE | 5 |
| Jeske, WP; Walenga, JM | 1 |
| Eckernkamp, A; Geinacher, A; Hinz, P; Lubenow, N | 1 |
| Eikelboom, JW; Hankey, GJ | 1 |
| Nguyen, PH; Rice, L; Vann, AR | 1 |
| Ibbotson, T; Perry, CM | 1 |
| Greinacher, A; Lubenow, N | 3 |
| Bauersachs, R; Lindhoff-Last, E | 1 |
| Carlos, R; Gal, P; Nguyen, TN; Ransom, JL | 1 |
| André, E; Briquel, ME; de Maistre, E; Lecompte, T; Wahl, D | 1 |
| Bouchard, D; Carrier, M; Cartier, R; Pagé, P; Pellerin, M; Perrault, LP; Robitaille, D | 1 |
| Kroll, H; Mertzlufft, F; Mörsdorf, S; Pindur, G; Schenk, JF; Seyfert, UT; Stephan, B; Wenzel, E | 1 |
| Myers, B; Strong, J; Westby, J | 1 |
| Carnelli, V; Gatti, L; Moia, M; Rusconi, R | 1 |
| Kodityal, S; Manhas, AH; Rice, L; Udden, M | 1 |
| Lakshmanan, S; Rittoo, D; Saha, B | 1 |
| Agnelli, G; Imberti, D; Silvestrini, E; Taliani, MR; Verso, M | 1 |
| Cleveland, KW | 1 |
| Brémaud, M; De Maistre, E; Guerci, A; Junke, E; Lalot, JM; Lecompte, T; Longrois, D; Meistelman, C | 1 |
| Agnelli, G; Ceppi, S; Mazzarino, I; Paoletti, F; Stefanelli, M; Verso, M | 1 |
| Fehr, R; Gülke, C; Merz, S | 1 |
| Biesma, DH; Haas, FJ; Leusink, JA; Veth, G; Wester, JP | 1 |
| Opatrny, L; Warner, MN | 1 |
| Bourke, M; Lavalee, G; Mesana, T; Rubens, FD; Ruel, MA | 1 |
| Kreutzenbeck, HJ; Lindhoff-Last, E; Magnani, HN | 1 |
| Hassell, K | 1 |
| Bartholomew, JR | 1 |
| Greinacher, A; Krahn, EL; Lubenow, N; Magnani, HN; Sloane, DA; Warkentin, TE; Wessel, A | 1 |
| Schill, D | 1 |
| Matthai, WH | 1 |
| Davidson, S; Keeling, D; Watson, H | 1 |
| Gallus, A; Magnani, HN | 1 |
| Cecere, R; De Varennes, B; Ergina, P; Lachapelle, K; Wan, C; Warner, M | 1 |
| Francis, JL | 1 |
| Das, P; Hamdalla, H; Jozic, J; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Ziada, K | 1 |
| Almahameed, A; Napolitano, LM; Nasraway, SA; Warkentin, TE | 1 |
| Fraser, JF; O'Connor, ED | 1 |
| Haas, S; Höhnke, C | 1 |
| Marymont, JH; Murphy, GS | 1 |
| Becker, A; Benomar, A; Debrix, I; Flahault, A; Verdy, E | 1 |
| Greinacher, A; Selleng, K; Warkentin, TE | 1 |
| Davenport, A | 2 |
| Lindhoff-Last, E; Magnani, HN; Schindewolf, M | 1 |
| Bong, M; Di Cesare, PE; Patel, VP | 1 |
| Ahmed, I; Majeed, A; Powell, R | 1 |
| de Pont, AC; Hofstra, JJ; Meijers, JC; Pik, DR; Schultz, MJ | 1 |
| Jolicoeur, EM; Lopes, RD; Ohman, EM; Wang, T | 1 |
| Cappellini, MD; Cassinerio, E; Castelli, R; Fabris, F; Graziadei, G; Porro, F | 1 |
| Cruz-González, I; Jang, IK; Sánchez, PL; Sánchez-Ledesma, M | 1 |
| Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F | 1 |
| Bastien, O; Bauer, C; Ffrench, P; Hercule, C; Jegaden, O; Lehot, JJ; Vichova, Z | 1 |
| Lindhoff-Last, E; Schindewolf, M | 1 |
| Prechel, M; Walenga, JM | 1 |
| Rolfes, C; Steinfeldt, T | 1 |
| Harenberg, J; Kübler, W; Schwarz, F; Zimmermann, R | 1 |
| Greinacher, A; Kemkes-Matthes, B; Möckl, M; Mueller-Eckhardt, C; Philippen, KH; Schaefer, K | 1 |
| Magnani, HN | 1 |
| Baglin, TP; Keeling, DM; Richards, EM | 1 |
| Boon, DM; Kappers-Klunne, MC; Michiels, JJ; Stibbe, J; van Vliet, HH | 2 |
| Cyran, J; Greinacher, A; Scheffold, N | 1 |
| Borris, LC; Lassen, MR | 1 |
| Burkhard-Meier, U; Greinacher, A; Heyll, A; Schneider, W; Schultheiss, HP; Schwartzkopff, B; Söhngen, D; Vogt, M | 1 |
| Herzog, S; Kuhn, W; Rath, W | 1 |
| Beraud, AM; Favre, JP; Guyotat, D; Mahul, P; Tardy, B; Tardy/Poncet, B | 1 |
| Aulmann, M; Fleischer, F; Martin, E; Nawroth, P; Remppis, A; Scheffler, E; Ziegler, R | 1 |
| Auboyer, C; Décousus, H; Favre, JP; Jospé, R; Mahul, P; Raynaud, J | 1 |
| Eckhardt, T; Greinacher, A; Mueller-Eckhardt, C; Mussmann, J | 1 |
| Humphrey, PW; Keller, MP; Kikta, MJ; Silver, D | 1 |
| Kleinschmidt, S; Seyfert, UT | 1 |
| Agnelli, G; de Angelis, V; Iorio, A; Nenci, GG | 1 |
| Kwan, YL; Kyle, PW; Manoharan, A; Ramakrishna, R | 1 |
| Abdelouahed, M; Bara, L; Elalamy, I; Lecrubier, C; Marie, JP; Potevin, F; Samama, M | 1 |
| Kececioglu, D; Möllhoff, T; Ostermann, H; Scheld, HH; Schmid, C; Wilhelm, MJ | 1 |
| Görres, G; Marbet, GA; Ritz, R; Stöckli, TC; Walther, A | 1 |
| Nawarskas, JJ; Spinler, SA | 1 |
| Greinacher, A; Kirschke, W; Klement, D; Kniemeyer, HW; Rammos, S; v Kries, R | 1 |
| Daoudal, P; Delacour, JL; Floriot, C; Lamriben, L; Ory, JP; Tiberghien, F; Wagschal, G | 1 |
| Leffringhausen, W; Scherlitzky, L; Wenzl, ME | 1 |
| Bartholomew, JR; Insler, SR; Kottke-Marchant, K; Kraenzler, EJ; Lytle, B; Starr, NJ | 1 |
| Claeys, L; Ehringer, H; Huk, I; Koppensteiner, R; Kyrle, PA; Minar, E; Muhm, M; Polterauer, P; Stümpflen, A | 1 |
| Ganjoo, AK; Harloff, MG; Schmahl, KS | 1 |
| Harenberg, J; Heene, DL; Huhle, G; Piazolo, L; Wang, LU | 1 |
| Henderson, S; Hickton, C; Hill, GR; Patton, WN | 1 |
| Buchwald, AB; Emig, U; Meyer, T | 1 |
| Peters, FP | 1 |
| Deeb, M; Drenger, B; Eldor, A; Gillis, S; Hyam, E; Merin, G; Zahger, D | 1 |
| Amiral, J; Borg, JY; Delahousse, B; Gruel, Y; Pouplard, C; Vissac, AM | 1 |
| Kuhn, B | 1 |
| Berkowitz, SD; deBruijn, N; Grocott, HP; Landolfo, K; Root, J | 1 |
| Markham, A; Wilde, MI | 1 |
| Alving, BM; Danby, CA; Jackson, MR | 1 |
| Lindhoff-Last, E; Lischke, V; Martens, S; Matheis, G; Strouhal, U; Westphal, K; Wimmer-Greinecker, G | 1 |
| Deeb, GM; Gitlin, SD; Schmaier, AH; Yann, C | 1 |
| Christiansen, S; Geiger, A; Reidemeister, JC; Splittgerber, FH | 1 |
| Bevan, D; Farnsworth, G; Haxby, EJ; Kanagasabay, RR; Robinson, G; Smith, EE; Unsworth-White, MJ | 1 |
| Christin, F; Loeb, JP; Theissen-Laval, O | 1 |
| Mazet, E; Piot, M; Tardy, B; Tardy-Poncet, B; Viallon, A | 1 |
| Ermacora, P; Lemesle, FG; Lhuillier, P; Marfaing, A; Mebroukine, L; Wolf, M | 1 |
| Braden, GA; Hale, LP; Owen, J; Smith, K | 1 |
| Chong, BH; Ortel, TL | 1 |
| Byrne, JL; Cassidy, MJ; Haynes, AP; Roe, SD | 1 |
| Fischer, KG | 1 |
| Agnelli, G; Gianese, F; Nenci, GG; Taliani, MR | 1 |
| Harenberg, J; Hoffmann, V; Huhle, G; Malsch, R; Song, XL; Wang, LC | 1 |
| Breithardt, OA; Greinacher, A; Janssens, U | 1 |
| Albrecht, D; Budde, U; Eichler, P; Greinacher, A; Haas, S; Kroll, H; Loreth, RM; Meyer, O; Pachmann, U; Pötzsch, B; Schabel, A | 1 |
| Cornillet-Lefebvre, P; de Maistre, E; Lecompte, T; Nguyen, P; Regnault, V | 1 |
| Altermann, WW; Fuchs, D; Greinacher, A; Gruhn, B; Sauer, M; Völpel, H; Zintl, F | 1 |
| Jang, IK; Januzzi, JL | 1 |
| Guyotat, D; Mahul, P; Mazet, E; Mismetti, P; Reynaud, J; Tardy, B; Tardy-Poncet, B | 1 |
| Bayerl, C; Harenberg, J; Hoffmann, U; Huhle, G; Kerowgan, M; Wang, L | 1 |
| Greinacher, A; Ranze, O | 1 |
| Black, MD; Edgell, D; Leaker, MT; Noel, D; Saxon, BR | 1 |
| Boneu, B | 1 |
| Mörsdorf, S; Orthleb, R; Pindur, G; Pistorius, G; Schenk, J | 1 |
| Ariano, RE; Bhattacharya, SK; Brownell, LG; Moon, M | 1 |
| Greinacher, A; Magnani, HN; Ranze, O; Ranze, P | 1 |
| Ariano, RE; Wazny, LD | 1 |
| Christiansen, S; Hammel, D; Jahn, UR; Kehrel, BE; Meyer, J; Scheld, HH; Van Aken, H | 1 |
| Barratt, SM; Edwards, RC; Ruff, SJ | 1 |
| Conard, J; Elalamy, I; Helft, G; Page, Y; Tardy, B; Viallon, A | 1 |
| Ben Ami, R; Berliner, S; Rachmimov, R | 1 |
| Farnsworth, G; Haxby, EJ; Kanagasabay, R; Smith, EE; Unsworth-White, MJ | 1 |
| Goetschel, P; Leumann, E; Neuhaus, TJ; Schmugge, M | 1 |
| Hausmann, H; Hetzer, R; Koster, A; Kuppe, H; Mertzlufft, F; Meyer, O | 1 |
| Baumgärtel, MW; Eichler, P; Glöckner, WM; Greinacher, A; Ranze, O | 1 |
| Ignaszewski, AP; Pamboukian, SV; Ross, HJ | 1 |
| Caiola, E | 1 |
| Boinot, C; Brizard, A; Chamlian, V; Gruel, Y; Guicheteau, M; Macchi, L; Magnin, G; Pourrat, O; Sarfati, R | 1 |
| Brouwer, DJ; Peterson, P | 1 |
| Cleland, AG; Fernandes, P; Hay-McKay, C; MacDonald, JL; Mayer, R | 1 |
| Lobato, EB; Olin, DA; Urdaneta, F | 1 |
| Alvarez, MJ; Mezzatesta, PJ | 1 |
| de Saint-Blanquat, L; Hamza, J; Simon, L; Toubas, MF | 1 |
| Conard, J; Elalamy, I; Horellou, MH; Lecrubier, C; Samama, MM | 1 |
| Bertrand, M; Boccara, G; Godet, G; Koskas, F; Van de Steen, E | 1 |
| Aouifi, A; Bastien, OH; Blanc, P; Ffrench, P; Hanss, M; Lehot, JJ; Piriou, V | 1 |
| Acostamadiedo, JM; Iyer, UG; Owen, J | 1 |
| Carbognani, D; Folliguet, T; Laborde, F; Le Bret, E; Pineau, E; Saint Maurice, OS | 1 |
| Eichler, P; Farner, B; Greinacher, A; Kroll, H | 1 |
| Covi, P; Grubbauer, HM; Kroll, H; Kurnik, K; Muntean, W; Rettenbacher, A; Zenz, W; Zöhrer', B | 1 |
| Chong, BH; Keng, TB | 1 |
| Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK | 1 |
| Bach, F; Kleinschmidt, S; Mertzlufft, F; Plinkert, PK | 1 |
| Duvaldestin, P; Gouault-Heilmann, M; LeBesnerais, P; Leroy-Matheron, C; Rosanval, O; Salmi, L | 1 |
| Gill, J; Kovacs, MJ | 1 |
| Arthur, C; Cade, JF; Chesterman, CN; Chong, BH; Gallo, J; Gallus, AS; Lloyd, J; Magnani, H; Manoharan, A; Oldmeadow, M; Rickard, K; Seshadri, P | 1 |
| Dager, WE; White, RH | 1 |
| Allard, S; Cohen, H; de Swiet, M; Letsky, E; Woo, YL | 1 |
| Bernat, C; Bontoux, L; Brunel, P; Cognet, F; Dubus-Bausière, V; Ménoret, N; Plassat, R; Richard, I; Ternisien, C | 1 |
| Dworschak, M; Hiesmayr, JM; Lassnigg, A | 1 |
| Budde, U; Harenberg, J; Koch, S; Odel, M; Schmidt-Gayk, H; Walch, S | 1 |
| Glomset, JA; Ross, R | 1 |
| Drost, W; Glaser, M; Gottsmann, M; Greinacher, A; Kohl, HJ; Leitl, J; Michels, I; Mueller-Eckhardt, C | 1 |
| Califf, RM; Gockerman, JP; Greenberg, CS; McCann, RL; Metzler, DM; O'Connor, CM; Ortel, TL | 1 |
| Chong, BH; Magnani, HN | 1 |
| Cannell, PK; Herrmann, RP; Marshall, LR | 1 |
| Ansell, J; Cola, C | 1 |
| Evans, S; Mansberg, R; Murray, B; Rowlings, PA; Rozenberg, MC | 1 |
| Golichowski, A; Hoffman, R; van Besien, K | 1 |
| John, G; Mudaliar, Y; Shehabi, Y | 1 |
| Chong, BH; Jacques, T | 1 |
| Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM | 1 |
| Fareed, J; Hoppensteadt, DA; Walenga, JM | 1 |
| Messmore, HL | 1 |
| Cade, J; Chesterman, CN; Chong, BH; Gallus, AS; Gordon, S; Ismail, F | 1 |
| Cade, JF; Chong, BH; Grigg, LE; Kiers, L; Street, PR | 1 |
| Barradas, MA; Dandona, P; Gracey, L; Jeremy, JY; Mikhailidis, DP; Wakeling, A | 1 |
58 review(s) available for dermatan sulfate and Thrombocytopenia
| Article | Year |
|---|---|
Heparin-induced thrombocytopaenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia | 2018 |
Nonheparin anticoagulants for heparin-induced thrombocytopenia.
Topics: Antibodies; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Immunoglobulin G; Male; Middle Aged; Platelet Activation; Platelet Count; Platelet Factor 4; Polysaccharides; Practice Guidelines as Topic; Thrombocytopenia; Venous Thrombosis; Vitamin K | 2013 |
Argatroban: for a few selected patients.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Substitution; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Patient Selection; Pipecolic Acids; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2013 |
CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Middle Aged; Pipecolic Acids; Practice Guidelines as Topic; Sulfonamides; Thrombocytopenia | 2015 |
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].
Topics: Arginine; Chondroitin Sulfates; Costs and Cost Analysis; Dermatan Sulfate; Germany; Hemorrhage; Heparin; Heparitin Sulfate; Hospitalization; Humans; Pipecolic Acids; Risk Factors; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2017 |
Heparin-induced thrombocytopenia: what clinicians need to know.
Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Monitoring, Physiologic; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Safety Management; Severity of Illness Index; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Time Factors | 2009 |
Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
Topics: Animals; Anticoagulants; Chondroitin Sulfates; Complement Activation; Dermatan Sulfate; Drug Contamination; Enzyme Activation; Heparin; Humans; Platelet Factor 4; Prekallikrein; Serotonin; Thrombocytopenia | 2011 |
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin | 2002 |
Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Topics: Anticoagulants; Biological Availability; Chondroitin Sulfates; Dermatan Sulfate; Disseminated Intravascular Coagulation; Drug Combinations; Heparitin Sulfate; Humans; Injections, Intravenous; Injections, Subcutaneous; Randomized Controlled Trials as Topic; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2002 |
Hirudin in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2002 |
Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Lactation; Pregnancy; Pregnancy Complications; Thrombocytopenia; Warfarin | 2002 |
[Heparin-induced thrombopenia].
Topics: Antibodies; Anticoagulants; beta-Thromboglobulin; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Drug Utilization; Enzyme-Linked Immunosorbent Assay; Heparin; Heparitin Sulfate; Hirudins; Humans; Interleukin-8; Peptides; Platelet Count; Platelet Factor 4; Recombinant Proteins; Risk Factors; Thrombocytopenia; Time Factors | 1999 |
Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Costs; Drug Monitoring; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2003 |
Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Thrombin; Thrombocytopenia; Thrombosis | 2001 |
Treatment of 51 pregnancies with danaparoid because of heparin intolerance.
Topics: Adult; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Evaluation; Drug Hypersensitivity; Exanthema; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; MEDLINE; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Retrospective Studies; Thrombocytopenia; Thrombosis | 2005 |
The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
Topics: Angina, Unstable; Antibodies; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Multiple Organ Failure; Platelet Factor 4; Polysaccharides; Pregnancy; Preoperative Care; Recombinant Proteins; Thrombin; Thrombocytopenia; Venous Thrombosis | 2005 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anticoagulants; Child; Child, Preschool; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Administration Schedule; Exanthema; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Infant; Male; Middle Aged; Postoperative Hemorrhage; Practice Guidelines as Topic; Thrombocytopenia; Thromboembolism | 2006 |
Heparin-induced thrombocytopenia and cardiovascular diseases.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia; Thrombosis | 2006 |
Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Care; Dermatan Sulfate; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Count; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2006 |
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Topics: Ancrod; Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
Heparin-induced thrombocytopenia in intensive care patients.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudins; Humans; Intensive Care Units; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis | 2007 |
Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Intensive Care Units; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2007 |
Heparin-induced thrombocytopenia and thrombosis.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2007 |
Heparin induced thrombocytopenia: diagnosis and management update.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2007 |
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Fondaparinux; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombocytopenia; Vitamin K | 2007 |
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
[Heparin-induced thrombocytopenia].
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enzyme-Linked Immunosorbent Assay; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Hirudins; Peptide Fragments; Pipecolic Acids; Platelet Factor 4; Platelet Function Tests; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2008 |
A comparative review of the adverse effect profiles of heparins and heparinoids.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Molecular Weight; Postoperative Complications; Thrombocytopenia; Thrombosis; Wound Infection | 1995 |
[Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Femoral Vein; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iliac Vein; Plasminogen Activators; Pulmonary Embolism; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator; Vena Cava Filters; Vena Cava, Inferior | 1997 |
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
Topics: Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparinoids; Heparitin Sulfate; Humans; Thrombocytopenia | 1997 |
Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Fibrin Tissue Adhesive; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 1997 |
Limitations of conventional treatment options for heparin-induced thrombocytopenia.
Topics: Ancrod; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Thrombocytopenia; Warfarin | 1998 |
New treatment options for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Pipecolic Acids; Randomized Controlled Trials as Topic; Sulfonamides; Thrombocytopenia | 1998 |
Heparin-induced thrombocytopenia: a ten-year retrospective.
Topics: Antibodies; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Gangrene; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Immunoglobulin G; Leg; Platelet Activation; Platelet Factor 4; Protein C Deficiency; Receptors, IgG; Recombinant Proteins; Retrospective Studies; Syndrome; Thrombin; Thrombocytopenia; Venous Thrombosis; Warfarin | 1999 |
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 1999 |
[Current treatment concepts in heparin-induced thrombocytopenia].
Topics: Adult; Anticoagulants; Child; Chondroitin Sulfates; Clinical Trials as Topic; Combined Modality Therapy; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Pregnancy; Thrombocytopenia | 1999 |
Treatment of heparin-induced thrombocytopenia.
Topics: Adult; Ancrod; Antibodies; Anticoagulants; Antigen-Antibody Complex; Antithrombins; Child; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Extracorporeal Circulation; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Platelet Factor 4; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Thrombolytic Therapy; Thrombosis | 1999 |
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
Topics: Adolescent; Anticoagulants; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Infant; Infant, Newborn; Male; Recombinant Proteins; Thrombocytopenia | 1999 |
Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient.
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Disease Management; Drug Combinations; Fibrinolytic Agents; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Interleukin-11; Recombinant Proteins; Thrombocytopenia; Thrombopoietin | 2000 |
Venous thromboembolism in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Humans; Leg; Pulmonary Embolism; Thrombocytopenia; Venous Thrombosis; Warfarin | 2000 |
Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Epoprostenol; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombocytopenia; Thrombosis | 2000 |
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Pathways; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2000 |
Heparin-induced thrombocytopenia: laboratory diagnosis and management.
Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Immunoassay; Platelet Activation; Recombinant Proteins; Thrombocytopenia | 2000 |
Danaparoid sodium.
Topics: Anticoagulants; Blood Coagulation Disorders; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparitin Sulfate; Humans; Thrombocytopenia | 2000 |
[Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Endocarditis; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heparin; Heparin Antagonists; Heparitin Sulfate; Humans; Male; Mitral Valve Insufficiency; Prosthesis Failure; Protamines; Reoperation; Thrombocytopenia; Treatment Outcome | 2001 |
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine | 2001 |
Treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Pregnancy; Rabbits; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
[Heparin induced thrombocytopenia: case report with acute thrombotic complications and literature review].
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombosis | 2002 |
The pathogenesis of atherosclerosis (first of two parts).
Topics: Adult; Aging; Animals; Arteries; Arteriosclerosis; Blood Platelets; Cell Division; Cells, Cultured; Child; Collagen; Dermatan Sulfate; Endothelium; Glycosaminoglycans; Haplorhini; Humans; Hypercholesterolemia; Muscle, Smooth; Thrombocytopenia | 1976 |
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis | 1990 |
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis | 1991 |
Clinical use of heparin fractions, fragments, and heparinoids.
Topics: Animals; Cardiopulmonary Bypass; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Factor X; Factor Xa; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Molecular Weight; Postoperative Complications; Rats; Renal Dialysis; Thrombocytopenia; Thrombosis; Uremia | 1985 |
11 trial(s) available for dermatan sulfate and Thrombocytopenia
| Article | Year |
|---|---|
Heparin versus danaparoid in off-pump coronary bypass grafting: results of a prospective randomized clinical trial.
Topics: Aged; Analysis of Variance; Anticoagulants; Blood Loss, Surgical; Blood Transfusion; Chondroitin Sulfates; Coronary Artery Bypass; Coronary Disease; Dermatan Sulfate; Double-Blind Method; Drug Combinations; Drug Monitoring; Factor Xa Inhibitors; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia; Troponin T | 2003 |
On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Selection; Platelet Count; Platelet Factor 4; Thrombocytopenia; Treatment Outcome | 2003 |
[Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thrombocytopenia; Thrombosis | 2007 |
Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Female; Gangrene; Heparin; Heparitin Sulfate; Humans; Middle Aged; Phenprocoumon; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Recurrence; Systemic Inflammatory Response Syndrome; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1995 |
Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 1996 |
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome | 1999 |
In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
Topics: Anticoagulants; Blood Platelets; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Interactions; Heparin; Heparitin Sulfate; Humans; Platelet Aggregation; Platelet Count; Thrombocytopenia | 2000 |
A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.
Topics: Age Factors; Aged; Amputation, Surgical; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Evaluation; Female; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Incidence; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Surveys and Questionnaires; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2001 |
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Combinations; Drug Therapy, Combination; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Therapeutic Equivalency; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin | 2001 |
Orgaran in heparin-induced thrombocytopenia.
Topics: Antibody Specificity; Autoantibodies; Autoimmune Diseases; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Evaluation; Glycosaminoglycans; Hemofiltration; Heparin; Heparinoids; Heparitin Sulfate; Humans; Postoperative Complications; Thrombocytopenia; Thromboembolism | 1992 |
Clinical use of heparin fractions, fragments, and heparinoids.
Topics: Animals; Cardiopulmonary Bypass; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Factor X; Factor Xa; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Molecular Weight; Postoperative Complications; Rats; Renal Dialysis; Thrombocytopenia; Thrombosis; Uremia | 1985 |
146 other study(ies) available for dermatan sulfate and Thrombocytopenia
| Article | Year |
|---|---|
White Clot Syndrome.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Computed Tomography Angiography; Dermatan Sulfate; Diagnosis, Differential; Female; Heparin; Heparitin Sulfate; Humans; Platelet Count; Syndrome; Thrombectomy; Thrombocytopenia; Thrombosis | 2018 |
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2017 |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Venous Thromboembolism | 2018 |
Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Heparin; Heparitin Sulfate; Humans; Obesity, Morbid; Renal Dialysis; Thrombocytopenia; Thrombosis | 2019 |
Heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2013 |
Successful pregnancy after pulmonary embolism and heparin-induced thrombocytopenia--case report.
Topics: Acenocoumarol; Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Gestational Age; Heparin; Heparitin Sulfate; Hirudins; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pulmonary Embolism; Recombinant Proteins; Thrombocytopenia; Venous Thrombosis | 2013 |
Heparin-induced thrombocytopenia after ICD-lead flushing.
Topics: Antibodies; Anticoagulants; Cardiomyopathy, Dilated; Chondroitin Sulfates; Defibrillators, Implantable; Dermatan Sulfate; Female; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Middle Aged; Platelet Aggregation; Platelet Factor 4; Postoperative Complications; Pulmonary Embolism; Thrombocytopenia; Treatment Outcome; Venous Thromboembolism | 2014 |
Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Chondroitin Sulfates; Citrates; Dermatan Sulfate; Equipment Failure; Female; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Platelet Factor 4; Renal Dialysis; Shock, Septic; Thrombocytopenia; Thrombosis | 2014 |
Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 2017 |
Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
Topics: Anticoagulants; Cardiac Surgical Procedures; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Heart Valve Diseases; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 2017 |
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Anticoagulants; Arginine; Biological Availability; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Infusions, Parenteral; Injections, Subcutaneous; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2008 |
Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
Topics: Antibodies; Antibody Affinity; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Platelet Activation; Platelet Factor 4; Polysaccharides; Protein Binding; Serine Proteinase Inhibitors; Thrombin; Thrombocytopenia | 2008 |
[Heparin-induced thrombocytopenia].
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombocytopenia | 2009 |
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |
[Cardiac surgery in patients with heparin-induced thrombocytopenia (HIT II)].
Topics: Anticoagulants; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin Antagonists; Heparitin Sulfate; Humans; Middle Aged; Postoperative Care; Preoperative Care; Thrombocytopenia | 2009 |
Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
Topics: Anticoagulants; Antithrombins; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Recombinant Proteins; Thrombocytopenia | 2009 |
[Headaches in a 21-year-old man with Goodpasture disease].
Topics: Anti-Glomerular Basement Membrane Disease; Anticoagulants; Chondroitin Sulfates; Combined Modality Therapy; Dermatan Sulfate; Diabetes Insipidus, Neurogenic; Disseminated Intravascular Coagulation; Enoxaparin; Fatal Outcome; Headache; Heparin; Heparitin Sulfate; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Plasma Exchange; Platelet Factor 4; Sinus Thrombosis, Intracranial; Thrombocytopenia; Young Adult | 2009 |
Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Clinical Laboratory Techniques; Data Collection; Dermatan Sulfate; Female; France; Heparin; Heparitin Sulfate; Hospitals, University; Humans; Male; Medical Records; Middle Aged; Practice Patterns, Physicians'; Thrombocytopenia; Thrombosis; Young Adult | 2010 |
The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
Topics: Aged; Anticoagulants; Blood Coagulation Disorders; Cerebral Hemorrhage; Chondroitin Sulfates; Chromosome Breakage; Chromosome Disorders; Dermatan Sulfate; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Treatment Outcome | 2011 |
Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis.
Topics: Anticoagulants; Cerebral Veins; Chondroitin Sulfates; Decompressive Craniectomy; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Intracranial Hypertension; Middle Aged; Platelet Count; Radiography; Thrombocythemia, Essential; Thrombocytopenia; Thrombosis; Treatment Outcome; Venous Thrombosis | 2011 |
Contaminants in heparin.
Topics: Animals; Anticoagulants; Chondroitin Sulfates; Complement Activation; Dermatan Sulfate; Drug Contamination; Enzyme Activation; Heparin; Humans; Platelet Factor 4; Prekallikrein; Serotonin; Thrombocytopenia | 2011 |
Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery.
Topics: Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Heparitin Sulfate; Humans; Middle Aged; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2011 |
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cardiac Catheterization; Cardiac Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vascular Surgical Procedures; Vitamin K; Young Adult | 2011 |
Immunogenic but effective: the HIT-fondaparinux brain puzzler.
Topics: Antibodies; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Male; Platelet Activation; Platelet Factor 4; Polysaccharides; Serotonin; Thrombocytopenia; Thromboembolism | 2011 |
Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Platelets; Calibration; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Pipecolic Acids; Plasma; Platelet-Rich Plasma; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors | 2013 |
[Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia].
Topics: Adult; Anticoagulants; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fractures, Bone; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Multiple Trauma; Platelet Count; Platelet Factor 4; Postoperative Complications; Recombinant Proteins; Thrombocytopenia; Thromboembolism | 2002 |
Low molecular weight heparins and heparinoids.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Myocardial Infarction; Thrombocytopenia; Venous Thrombosis | 2002 |
Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
Lepirudin use in a neonate with heparin-induced thrombocytopenia.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Heparin; Heparitin Sulfate; Hirudins; Humans; Infant, Newborn; Infant, Premature; Male; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2003 |
Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction.
Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Emergencies; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Injections, Subcutaneous; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, High-Risk; Pregnancy, Multiple; Puerperal Disorders; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Warfarin | 2003 |
Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate.
Topics: Anticoagulants; Child; Dermatan Sulfate; Heparin; Humans; Male; Necrosis; Protein C; Protein C Deficiency; Skin; Thrombocytopenia; Warfarin | 2003 |
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Disseminated Intravascular Coagulation; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Count; Thrombocytopenia; Thrombosis; Treatment Failure | 2003 |
HIT/HITT and alternative anticoagulation: current concepts.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia | 2003 |
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Dermatan Sulfate; Female; Heparin; Humans; Male; Middle Aged; Thrombocytopenia; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2003 |
[Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
Topics: Adult; Anticoagulants; Budd-Chiari Syndrome; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Factor Xa Inhibitors; Female; Heparin; Heparitin Sulfate; Humans; Infusions, Intravenous; Platelet Aggregation; Thrombocytopenia | 2004 |
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter-related deep vein thrombosis in a child with acute lymphoblastic leukemia.
Topics: Catheterization, Central Venous; Child; Dermatan Sulfate; Heparin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytopenia; Venous Thrombosis | 2004 |
[Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II].
Topics: Aged; Anticoagulants; Anticonvulsants; Blood Cell Count; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Male; Mental Disorders; Postoperative Complications; Seizures; Sinus Thrombosis, Intracranial; Thrombocytopenia; Tomography, X-Ray Computed | 2004 |
Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Risk Factors; Thrombocytopenia; Venous Thrombosis | 2004 |
Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Neoplasms; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2004 |
Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Topics: Aged; Anticoagulants; Blood Coagulation; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Plasma; Platelet Transfusion; Pulmonary Embolism; Recombinant Proteins; Thrombectomy; Thrombin; Thrombocytopenia; Time Factors; Warfarin | 2005 |
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
Topics: Aged; Ancrod; Canada; Chondroitin Sulfates; Cohort Studies; Coumarins; Dermatan Sulfate; Female; Germany; Heparin; Heparitin Sulfate; Humans; Male; Outcome Assessment, Health Care; Platelet Count; Practice Patterns, Physicians'; Retrospective Studies; Survival Analysis; Thrombocytopenia | 2006 |
[Sinus thrombosis in heparin-induced thrombocytopenia type II].
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Sinus Thrombosis, Intracranial; Thrombocytopenia | 2005 |
The management of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Cardiac Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Heparin; Heparitin Sulfate; Hirudins; Humans; Perioperative Care; Platelet Count; Platelet Function Tests; Recombinant Proteins; Thrombocytopenia | 2006 |
Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Autoantibodies; Cardiac Surgical Procedures; Chondroitin Sulfates; Cohort Studies; Dermatan Sulfate; Diabetes Complications; Female; Gangrene; Heparin; Heparitin Sulfate; Hospital Mortality; Humans; Ischemia; Male; Middle Aged; Platelet Factor 4; Postoperative Complications; Postoperative Period; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Treatment Outcome | 2006 |
Invited commentary.
Topics: Anticoagulants; Cardiac Surgical Procedures; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Platelet Count; Platelet Factor 4; Postoperative Complications; Postoperative Period; Serotonin; Thrombocytopenia; Time Factors; Treatment Outcome | 2006 |
[Two surgical case reports showing atypical heparin-induced thrombocytopenia].
Topics: Adult; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Eruptions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Pipecolic Acids; Platelet Count; Platelet Factor 4; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2007 |
[Multidisciplinary consultation for the prescription of danaparoid in suspected heparin-induced thrombocytopenia].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Prescriptions; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hospitalization; Humans; Middle Aged; Patient Care Team; Platelet Count; Probability; Referral and Consultation; Retrospective Studies; Thrombocytopenia; Time Factors | 2007 |
Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cohort Studies; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Hemofiltration; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Pilot Projects; Prospective Studies; Thrombocytopenia; Treatment Outcome | 2007 |
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism | 2007 |
Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Echocardiography, Transesophageal; Extracorporeal Membrane Oxygenation; Factor Xa; Heparitin Sulfate; Humans; Iliac Vein; Male; Portal Vein; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2008 |
Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
Topics: Abortion, Habitual; Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Factor V; Factor V Deficiency; Female; Heparin; Heparitin Sulfate; Homozygote; Humans; Infant, Newborn; Male; Platelet Count; Point Mutation; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Translocation, Genetic; Venous Thrombosis | 2008 |
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis | 2008 |
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1983 |
Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Molecular Weight; Renal Dialysis; Thrombocytopenia | 1993 |
Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)
Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Therapy, Combination; Female; Glycosaminoglycans; Hematologic Tests; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Treatment Outcome | 1993 |
Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Platelet Aggregation; Thrombocytopenia | 1994 |
Heparin-induced thrombocytopenia and antithrombotic therapy.
Topics: Adolescent; Adult; Aged; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia; Treatment Outcome; Warfarin | 1994 |
[Intracardial thrombus formation in heparin-associated thrombocytopenia type II].
Topics: Aged; Antibodies; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Chondroitin Sulfates; Coronary Thrombosis; Dermatan Sulfate; Echocardiography; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Mitral Valve Stenosis; Partial Thromboplastin Time; Phenprocoumon; Platelet Count; Thrombocytopenia; Thrombophlebitis | 1995 |
Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Embolism; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 1995 |
[Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Heparin; Heparitin Sulfate; Humans; Platelet Count; Pre-Eclampsia; Pregnancy; Puerperal Disorders; Thrombocytopenia; Thromboembolism | 1995 |
Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Treatment Failure | 1995 |
[Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation].
Topics: Adult; Aortic Valve Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heart Valve Prosthesis; Heparin; Heparitin Sulfate; Heroin Dependence; Humans; Male; Platelet Count; Postoperative Complications; Prosthesis Failure; Reoperation; Thrombocytopenia; Thrombosis | 1995 |
[Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
Topics: Anticoagulants; Blood Coagulation Tests; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Count; Renal Dialysis; Thrombocytopenia | 1995 |
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Embryonic and Fetal Development; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Thrombocytopenia | 1993 |
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia | 1993 |
Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatment.
Topics: Aged; Blood Coagulation Tests; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Count; Platelet Function Tests; Thrombocytopenia | 1995 |
Dermatan sulphate in heparin-induced thrombocytopenia.
Topics: Aged; Dermatan Sulfate; Female; Heparin; Humans; Thrombocytopenia | 1994 |
Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
Topics: Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Interactions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 1995 |
Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.
Topics: Cells, Cultured; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Platelet Aggregation; Polysaccharides; Thrombocytopenia | 1995 |
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
Topics: Adolescent; Adult; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Female; Heart Septal Defects, Atrial; Heart Valve Diseases; Heparin; Heparitin Sulfate; Humans; Male; Mitral Valve; Thrombocytopenia; Thromboembolism; Treatment Outcome | 1996 |
[Heparin-induced thrombopenia and thrombosis].
Topics: Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fractures, Bone; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Pelvic Bones; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1996 |
Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
Topics: Adolescent; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Male; Platelet Activation; Thrombocytopenia; Thrombophlebitis | 1996 |
[Value of orgaran in hemodialysis during heparin-induced thrombopenia].
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Renal Dialysis; Thrombocytopenia | 1996 |
[Loss of extremities caused by heparin-induced thrombocytopenia].
Topics: Aged; Amputation, Surgical; Arm; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Middle Aged; Platelet Aggregation; Risk Factors; Thrombocytopenia; Thrombosis | 1996 |
Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Thrombosis | 1997 |
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Topics: Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Dose-Response Relationship, Drug; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia; Thrombophlebitis | 1997 |
Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
Topics: Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Plasmapheresis; Thrombocytopenia | 1997 |
Anticoagulation in patients with heparin-induced thrombocytopenia type II.
Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Injections, Intravenous; Male; Middle Aged; Thrombocytopenia; Thromboembolism | 1997 |
The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Heparin; Heparitin Sulfate; Humans; Male; Platelet Aggregation; Reproducibility of Results; Thrombocytopenia | 1997 |
Treatment of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Heparin; Heparinoids; Heparitin Sulfate; Humans; Thrombocytopenia | 1997 |
Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
Topics: Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 1997 |
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibody Specificity; beta-Thromboglobulin; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Heparin; Heparitin Sulfate; Humans; Interleukin-8; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Thrombocytopenia | 1997 |
Ardeparin and danaparoid for prevention of deep vein thrombosis.
Topics: Abdomen; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophlebitis | 1997 |
[Heparin-induced thrombocytopenia--a serious complication within the scope of heparin therapy. Follow-up of 7 trauma surgery patients].
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Dermatan Sulfate; Female; Femoral Neck Fractures; Heparin; Heparitin Sulfate; Hip Fractures; Humans; Male; Middle Aged; Multiple Trauma; Osteoarthritis, Hip; Platelet Count; Postoperative Complications; Thrombocytopenia; Thromboembolism | 1997 |
Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
Topics: Aged; Anticoagulants; Blood Coagulation; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia | 1997 |
Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Coronary Artery Bypass; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Thrombocytopenia | 1997 |
Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.
Topics: Adult; Anticoagulants; Blood Coagulation Tests; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Drug Combinations; Drug Monitoring; Factor Xa Inhibitors; Female; Heart Transplantation; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Monitoring, Intraoperative; Platelet Activation; Thrombocytopenia; Time Factors | 1998 |
Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
Topics: Aged; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Artery Bypass; Coronary Disease; Dermatan Sulfate; Drug Combinations; Heparin; Heparinoids; Heparitin Sulfate; Humans; Intraoperative Care; Male; Postoperative Hemorrhage; Saphenous Vein; Thrombocytopenia | 1998 |
Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
Topics: Ancrod; Anticoagulants; Aortic Valve Stenosis; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Disease; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Middle Aged; Thrombocytopenia | 1998 |
[Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Hemofiltration; Heparitin Sulfate; Humans; Thrombocytopenia | 1998 |
Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
Topics: Aged; Anticoagulants; Arteries; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fatal Outcome; Heparinoids; Heparitin Sulfate; Humans; Male; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1998 |
[Thrombosis, low-molecular-weight heparin-induced thrombocytopenia and labor].
Topics: Adult; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparitin Sulfate; Humans; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Thrombocytopenia; Thrombophlebitis; Ultrasonography, Doppler | 1998 |
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
Topics: Abciximab; Antibodies; Antibodies, Monoclonal; Anticoagulants; Atherectomy, Coronary; Blood Coagulation; Chondroitin Sulfates; Coronary Angiography; Coronary Disease; Dermatan Sulfate; Heparin; Heparinoids; Heparitin Sulfate; Humans; Immunoglobulin Fab Fragments; Intraoperative Period; Male; Middle Aged; Thrombocytopenia | 1998 |
[Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombophlebitis | 1998 |
Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Lung Diseases; Male; Phlebography; Renal Dialysis; Thrombocytopenia; Venous Thrombosis | 1998 |
[Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia | 1998 |
[Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
Topics: Anticoagulants; Antithrombin III; Antithrombins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Femoral Vein; Fibrinolytic Agents; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Humans; Iliac Vein; Thrombocytopenia; Thrombolytic Therapy; Vena Cava, Inferior; Venous Thrombosis | 1999 |
Dermatan sulphate in patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Dermatan Sulfate; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Thrombocytopenia; Thromboembolism | 1999 |
Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Kidney; Multiple Trauma; Platelet Count; Pregnancy; Recurrence; Renal Replacement Therapy; Rupture; Suicide, Attempted; Thrombocytopenia | 1998 |
Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II.
Topics: Adult; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Immunoglobulin G; Sensitivity and Specificity; Thrombocytopenia | 1999 |
Successful thrombolysis of right atrial and ventricle thrombi encircling a temporary pacemaker lead in a patient with heparin-induced thrombocytopenia type II.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heart Atria; Heart Diseases; Heart Ventricles; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pacemaker, Artificial; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1999 |
First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA.
Topics: Antibodies; Anticoagulants; Antigens, Human Platelet; Blood Donors; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Enzyme-Linked Immunosorbent Assay; False Negative Reactions; False Positive Reactions; Heparin; Heparitin Sulfate; Humans; Methods; Platelet Activation; Platelet Factor 4; Reproducibility of Results; Thrombocytopenia | 1999 |
Heparin-induced thrombocytopenia in France, 1980-1998.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enzyme-Linked Immunosorbent Assay; France; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Platelet Aggregation; Platelet Function Tests; Recombinant Proteins; Thrombocytopenia | 1999 |
Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
Topics: Adult; Anticoagulants; Bone Marrow Transplantation; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enzyme Activation; Female; Fibrinolytic Agents; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Humans; Protein C; Recombinant Proteins; Thrombocytopenia | 1999 |
Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Hypersensitivity, Delayed; Immunoglobulin G; Injections, Subcutaneous; Male; Middle Aged; Platelet Activation; Skin Tests; Thrombocytopenia | 1999 |
Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Topics: Anticoagulants; Cardiopulmonary Bypass; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heart Defects, Congenital; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombosis | 1999 |
[Anticoagulants in clinical practice].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Thrombocytopenia; Vitamin K | 1999 |
[Late onset of heparin-induced thrombocytopenia with recurrent arterial thromboses and amputation].
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Endarterectomy; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Ischemia; Leg; Recurrence; Thrombocytopenia; Thromboembolism; Thrombosis | 1999 |
Failure of danaparoid anticoagulation for cardiopulmonary bypass.
Topics: Aged; Angina, Unstable; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Disease; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Male; Reoperation; Thrombocytopenia; Thrombosis; Treatment Failure | 2000 |
Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heart-Assist Devices; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Male; Middle Aged; Thrombocytopenia | 2000 |
Heparin-induced thrombocytopenia and its treatment.
Topics: Ancrod; Anticoagulants; Antithrombins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombosis; Warfarin | 2000 |
Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Female; Heparitin Sulfate; Humans; Middle Aged; Platelet Count; Radionuclide Imaging; Thrombocytopenia; Warfarin | 2000 |
[Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia | 1999 |
[Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
Topics: Aged; Aged, 80 and over; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Nephrotic Syndrome; Platelet Aggregation; Renal Dialysis; Thrombocytopenia | 1999 |
Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Topics: Ancrod; Anticoagulants; Aprotinin; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Disease; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Serine Proteinase Inhibitors; Thrombocytopenia; Thrombosis; Treatment Failure | 2000 |
Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
Topics: Adolescent; Anticoagulants; Child; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Platelet Count; Renal Dialysis; Thrombocytopenia | 2000 |
Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin)
Topics: Antibodies; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Middle Aged; Recombinant Proteins; Thrombocytopenia | 2000 |
Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Fatal Outcome; Female; Heart Transplantation; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Thrombocytopenia; Warfarin | 2000 |
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Topics: Adult; Anticoagulants; Aspirin; Asthma; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Risk Factors; Thrombocytopenia; Thromboembolism | 2000 |
Heparin-induced thrombocytopenia in hemodialysis patients.
Topics: Anticoagulants; Body Weight; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Drug Monitoring; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Renal Dialysis; Thrombocytopenia | 2000 |
Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
Topics: Adult; Aged; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Postoperative Complications; Thrombocytopenia | 2000 |
Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Artery Bypass; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heart-Lung Transplantation; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 2000 |
Aprotinin and organon 10172: a successful combination for coronary artery bypass surgery complicated by heparin-induced thrombocytopenia.
Topics: Anticoagulants; Aprotinin; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Hemostatics; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 2000 |
[Treatment with danaparoid during pregnancy for a woman with a cutenous allergy to low-molecular-weight heparin] .
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Drug Hypersensitivity; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications; Thrombocytopenia | 2000 |
[Thromboembolytic complications. Alternative anticoagulation in HIT II].
Topics: Anticoagulants; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Drug Combinations; Heparitin Sulfate; Humans; Thrombocytopenia | 2000 |
[Thrombopenia increased by heparin and danaparoid].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Captopril; Carotid Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Hypertension; Stroke; Thrombocytopenia | 2001 |
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Drug Combinations; Epoprostenol; Female; Heart Valve Prosthesis Implantation; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Premedication; Thrombocytopenia | 2001 |
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Child; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Thrombosis; Treatment Outcome | 2001 |
Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin.
Topics: Aged; Antibodies; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Factor Xa; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; International Normalized Ratio; Male; Platelet Count; Syndrome; Thrombocytopenia; Thrombosis | 2001 |
[Heparin-induced thrombocytopenia (HIT). Problems and their significance for ENT medicine].
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Otorhinolaryngologic Diseases; Risk Factors; Thrombocytopenia; Thromboembolism | 2001 |
[Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Extracorporeal Circulation; Female; Heart Valve Prosthesis; Heparin; Heparitin Sulfate; Humans; Middle Aged; Mitral Valve Insufficiency; Thrombocytopenia | 2001 |
Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, Multiple; Thrombocytopenia; Twins; Venous Thrombosis | 1997 |
Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Antithrombin III; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Treatment Outcome | 2002 |
Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
Topics: Anticoagulants; Chondroitin Sulfates; Citric Acid; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Emergencies; Factor Xa Inhibitors; Female; Heart Failure; Hemofiltration; Heparin; Heparitin Sulfate; Humans; Middle Aged; Platelet Aggregation; Platelet Count; Thrombocytopenia | 2002 |
Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Blood Platelets; Chondroitin Sulfates; Chromatography, High Pressure Liquid; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Predictive Value of Tests; Sensitivity and Specificity; Serotonin; Single-Blind Method; Thrombocytopenia | 2002 |
Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
Topics: Aged; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Male; Thrombocytopenia | 1992 |
Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia; Thrombosis | 1992 |
Successful use of the APTT in monitoring of the anti-factor Xa activity of the heparinoid organon 10172 in a case of HITS requiring open heart surgery.
Topics: Antibodies, Monoclonal; Anticoagulants; Chondroitin Sulfates; Coronary Artery Bypass; Dermatan Sulfate; Factor Xa; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Monitoring, Physiologic; Partial Thromboplastin Time; Thrombocytopenia | 1992 |
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
Topics: Aged; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Renal Dialysis; Thrombocytopenia; Thrombosis | 1991 |
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Lupus Coagulation Inhibitor; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia | 1991 |
Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
Topics: Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Extracorporeal Circulation; Female; Glycosaminoglycans; Hemofiltration; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Dialysis; Thrombocytopenia | 1991 |
Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemofiltration; Heparin; Heparitin Sulfate; Humans; Renal Dialysis; Thrombocytopenia | 1991 |
Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
Topics: Animals; Cattle; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Platelet Activation; Platelet Aggregation; Swine; Thrombocytopenia | 1991 |
Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.
Topics: Antigen-Antibody Reactions; Blood Platelets; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; In Vitro Techniques; Molecular Weight; Platelet Aggregation Inhibitors; Thrombocytopenia; Thrombosis; Thromboxane B2 | 1989 |
Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombophlebitis | 1986 |
Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease.
Topics: Adolescent; Adult; Aged; Anorexia Nervosa; Blood Platelets; Chondroitin Sulfates; Collagen; Dermatan Sulfate; Epinephrine; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia; Thromboembolism; Thromboxane B2; Vascular Diseases | 1985 |